Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

• Main Authors: Jorge A. Alegría-Baños (Author), José C. Jiménez-López (Author), Arely Vergara-Castañeda (Author), David F. Cantú de León (Author), Alejandro Mohar-Betancourt (Author), Delia Pérez-Montiel (Author), Gisela Sánchez-Domínguez (Author), Mariana García-Villarejo (Author), César Olivares-Pérez (Author), Ángel Hernández-Constantino (Author), Acitlalin González-Santiago (Author), Miguel Clara-Altamirano (Author), Liz Arela-Quispe (Author), Diddier Prada-Ortega (Author)
• Format: Book
• Published: BMC, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of which more than 65% cases are diagnosed in advanced stages, requiring platinum-based neoadjuvant chemotherapy (NACT). Methods A prospective-longitudinal study was conducted among women with advanced epithe...